Pharmacodynamics of PEG-IFN alpha-2a and HCV response as a function of IL28B polymorphism in HIV/HCV co-infected patients

Схожие документы

• Pharmacodynamics of PEG-IFN alpha-2a in HIV/HCV co-infected patients: Implications for treatment outcomes
  по: Dahari, Harel, et al.
  Опубликовано: (2010)
• Very early prediction of response to HCV treatment with peg-IFN-alfa-2a and ribavirin in HIV/HCV coinfected patients
  по: Araújo, Evaldo Stanislau A., et al.
  Опубликовано: (2011)
• Understanding triphasic HCV decline during treatment in the era of IL28B polymorphisms and direct acting antiviral agents via mathematical modeling
  по: Dahari, Harel, et al.
  Опубликовано: (2012)
• Basic aspects of the treatment for hepatitis C: mechanisms of action of interferon alpha and ribavirin and the bases of individualization
  по: Carlos Eduardo de Melo, et al.
• Therapeutic Response to Peg IFN-alpha-2b and Ribavirin in HIV/HCV Co-infected African American and Caucasian Patients as a function of HCV Viral Kinetics and Interferon Pharmacodynamics
  по: Rozenberg, L, et al.
  Опубликовано: (2009)